Fabrication of nano-decorated ZnO-fibrillar chitosan exhibiting a superior performance as a promising replacement for conventional ZnO.


Journal

Carbohydrate polymers
ISSN: 1879-1344
Titre abrégé: Carbohydr Polym
Pays: England
ID NLM: 8307156

Informations de publication

Date de publication:
15 Nov 2021
Historique:
received: 01 07 2021
revised: 09 08 2021
accepted: 01 09 2021
entrez: 27 10 2021
pubmed: 28 10 2021
medline: 8 2 2022
Statut: ppublish

Résumé

In this research, bioactive nano-hybrids based on the nano-fibrillar chitosan-ZnO (NF-CS-ZnO) were synthesized to diminish the toxicity of ZnO-NPs. The successful formation of nano-hybrids was confirmed by FT-IR, UV-Vis, and FE-SEM analyses, showing a uniform spherical ZnO-NPs with an average diameter of 20-30 nm, homogeneously dispersed on NF-CS. The obtained results demonstrated a remarkable antibacterial activity of NF-CS-ZnO-0.6 nano-hybrid against E. coli and S. aureus and, interestingly, no cytotoxic on normal cells (even at a high concentration of 100 μg/mL). Furthermore, NF-CS hybridization efficiently decreased the up-regulation in Cas3, Cas9, and Il6 of inspected fishes compared to the ZnO-NPs. Histopathological examination revealed hepatocyte necrosis in the fish exposed to ZnO-NPs and hyperemia exposed to NF-CS-ZnO-0.6 nano-hybrid. Finally, NF-CS efficiently improved the bio-safety and bactericidal activity of ZnO-NPs; therefore, NF-CS-ZnO nano-hybrid is prominently recommended as a talented low-toxicity antibacterial agent replacement of conventional ZnO-NPs for use in different applications.

Identifiants

pubmed: 34702461
pii: S0144-8617(21)01026-2
doi: 10.1016/j.carbpol.2021.118639
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Chitosan 9012-76-4
Zinc Oxide SOI2LOH54Z

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

118639

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Auteurs

Erfan Zabihi (E)

Metabolic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran; Department of Polymer Engineering, Faculty of Engineering, Golestan University, Gorgan, Iran.

Zahra Arab-Bafrani (Z)

Metabolic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran; Department of Biochemistry and Biophysics, Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Iran; Cancer Research Center, Golestan University of Medical Sciences, Gorgan, Iran. Electronic address: arabbafrani@goums.ac.ir.

Seyyed Morteza Hoseini (SM)

Inland Waters Aquatics Resources Research Center, Iranian Fisheries Sciences Research Institute, Agricultural Research, Education and Extension Organization, Gorgan, Iran.

Elham Mousavi (E)

Medical Mycology and Bacteriology Research Center, Kerman University of Medical Sciences, Kerman, Iran; Department of Microbiology and Virology, School of Medicine, Kerman University of Medical Sciences, Kerman, Iran.

Amir Babaei (A)

Department of Polymer Engineering, Faculty of Engineering, Golestan University, Gorgan, Iran. Electronic address: a.babaei@gu.ac.ir.

Mohsen Khalili (M)

Medical Cellular and Molecular Research Center, Golestan University of Medical Sciences, Gorgan, Iran.

Mohammad Mostakhdem Hashemi (MM)

Metabolic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran.

Naeme Javid (N)

Department of Molecular Medicine, Golestan University of Medical Sciences, Gorgan, Iran.

Articles similaires

Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Ahmed Hussein, Kateri L Schoettinger, Jourdan Hydol-Smith et al.
1.00
Humans Drug Hypersensitivity Syndrome Vancomycin Female Male
Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice

Classifications MeSH